You are here

Article Text

Article menu
Download PDFPDF
Letters
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study

https://doi.org/10.1136/ard.2010.137935

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding The study was partly financially supported by a grant from Novartis, Germany.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval This study was conducted with the approval of the local ethics committee.

    • Provenance and peer review Not commissioned; externally peer reviewed.